Advancements and Challenges in Abuse Potential Evaluation

October 11-12, 2018, Hyatt Regency Bethesda, Bethesda, MD

About This Conference

Organized by the Cross Company Abuse Liability Council (CCALC)  With scientific support from FDA   Participation by FDA and NIDA (National Institute on Drug Abuse) representatives.

Topics related to preclinical and clinical methods to evaluate the abuse and dependence potential of CNS-active drugs.  Focus on current challenges and further discussion of the 2017 FDA Guidance.

Oct 11: 8:30 am - 5:00 pm

Oct 12: 8:30 am - 1:30 pm

Reception: Oct 11: 5:30 - 7:00 pm


Conference Venue

Hyatt Regency Bethesda

Use this link to book your room at a special meeting rate (limited rooms available at discounted rate through September 21st, first come first served). 

General hotel information is below.

Hotel Reservations

Conference Registration

Use this link to register for the meeting.  Advanced registration is requested.  Registration fees will increase after 

October 1st.


General Hotel Information

Hotel Website

Hyatt Regency Bethesda

One Bethesda Metro Center (7400 Wisconsin Ave), Bethesda, MD 20814

+1 .301 .657. 1234